Historique
Bulletin de Périodique
Drug Testing and Analysis , Vol.14, n°1 - January 2022
Paru le :
01/01/2022
Année
2022
Page(s) :
1-196
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Note de contenu :
SELECTION :
- Detection of amfepramone and its metabolite cathinone in human hair: Application to a uthentic cases of amfepramone use. Yang H., Wang X., Liu M., Deng H., Yu M., Xiang P., p. 101-109.
- Prevalence and concentrations of new designer stimulants, synthetic opioids, benzodiazepines, and hallucinogens in postmortem hair samples: A 13-year retrospective study. Niebel A., Westendorf L., Krumbiegel F., Hartwig S., Parr M.K., Tsokos M., p. 110-121.
- Orally administered cannabidiol does not produce false-positive tests for ?9-tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000. McCartney D., Kevin R.C., Suraev A.S., Irwin C., Grunstein R.R., Hoyos C.M., et al., p. 137-143.
- Detection of amfepramone and its metabolite cathinone in human hair: Application to a uthentic cases of amfepramone use. Yang H., Wang X., Liu M., Deng H., Yu M., Xiang P., p. 101-109.
- Prevalence and concentrations of new designer stimulants, synthetic opioids, benzodiazepines, and hallucinogens in postmortem hair samples: A 13-year retrospective study. Niebel A., Westendorf L., Krumbiegel F., Hartwig S., Parr M.K., Tsokos M., p. 110-121.
- Orally administered cannabidiol does not produce false-positive tests for ?9-tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000. McCartney D., Kevin R.C., Suraev A.S., Irwin C., Grunstein R.R., Hoyos C.M., et al., p. 137-143.
Cote :
Abonnement